The pregnane X receptor (PXR) is a key regulator of metabolism, but the mechanisms underlying its antagonism remain unclear. Garcia-Maldonado et al. reported potent new antagonists and their co-crystal structures, revealing molecular determinants of PXR antagonism and paving the way for developing antagonists as therapeutics and preventing undesirable PXR activation.
Keywords: PXR; antagonist; crystal structures; drug discovery.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.